Starsource Multitrade

Starsource Multitrade ROCE

The Return on Capital Employed (ROCE) of Starsource Multitrade (506365.BO) as of Oct 27, 2026 is -0.42 %. In the previous year, Return on Capital Employed (ROCE) was -0.93 % — a change of -54.86% (higher).

ROCE

-0.42 %

YoY

-54.86%

Last updated:

In 2026, Starsource Multitrade's return on capital employed (ROCE) was -0.42 %, a -54.86% increase from the -0.93 % ROCE in the previous year.

The Starsource Multitrade ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2019
-5.49 INR
Jan 1, 2020
-4.33 INR
Jan 1, 2021
-1.46 INR
Jan 1, 2022
-3.67 INR
Jan 1, 2023
-1.91 INR
Jan 1, 2024
-1.52 INR
Jan 1, 2025
-0.93 INR
Jan 1, 2026
-0.42 INR
The Starsource Multitrade ROCE history
YEARROCEYoY
-0.42 %-54.86%
-0.93 %-39.05%
-1.52 %-20.53%
-1.91 %-47.84%
-3.67 %+150.90%
-1.46 %-66.23%
-4.33 %-21.19%
-5.49 %+73.54%
-3.17 %+52.12%
-2.08 %-123.98%
8.68 %+9.67%
7.91 %+22.48%
6.46 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Starsource Multitrade Stock analysis

What does Starsource Multitrade do? Starsource Multitrade Ltd focuses on acquiring power and chemicals businesses, having transitioned from its former role as a pharmaceutical company. The company is exploring new business opportunities in the power and chemicals sectors, aiming to expand its portfolio through strategic acquisitions. Chemo Pharma Laboratories Ltd, which was formerly a pharmaceutical company, is now part of this strategic shift, though it has no current operations. The firm targets opportunities in power and chemicals to build its business model. The company's primary revenue stream comes from acquiring and developing power and chemicals businesses, with Chemo Pharma Laboratories Ltd serving as a former entity that has shifted focus. It does not currently operate any pharmaceutical business, instead concentrating on power and chemicals acquisitions. The business model relies on identifying and integrating new acquisitions in the power and chemicals sectors to generate revenue. Starsource Multitrade Ltd is actively seeking to acquire businesses in the power and chemicals sectors, having moved away from its pharmaceutical roots. The firm has no current operations, indicating a focus on future acquisitions rather than existing business activities. Chemo Pharma Laboratories Ltd, once a pharmaceutical company, is now part of the company's strategic repositioning towards power and chemicals. Starsource Multitrade is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Starsource Multitrade's Return on Capital Employed (ROCE)

Starsource Multitrade's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Starsource Multitrade's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Starsource Multitrade's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Starsource Multitrade’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Starsource Multitrade stock

Return on Capital Employed (ROCE) of Starsource Multitrade is -0.42 % in 2026.

Return on Capital Employed (ROCE) of Starsource Multitrade changed from -0.93 % to -0.42 %, representing a -54.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Starsource Multitrade since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Starsource Multitrade with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Starsource Multitrade

All Key Metrics — Starsource Multitrade